Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2013 1
2014 4
2015 4
2016 1
2017 2
2019 5
2020 5
2021 5
2022 3
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Ceragenin-mediated disruption of Pseudomonas aeruginosa biofilms.
Wnorowska U, Łysik D, Piktel E, Zakrzewska M, Okła S, Lesiak A, Spałek J, Mystkowska J, Savage PB, Janmey P, Fiedoruk K, Bucki R. Wnorowska U, et al. Among authors: fiedoruk k. PLoS One. 2024 Feb 12;19(2):e0298112. doi: 10.1371/journal.pone.0298112. eCollection 2024. PLoS One. 2024. PMID: 38346040 Free PMC article.
Ceragenins exhibit bactericidal properties that are independent of the ionic strength in the environment mimicking cystic fibrosis sputum.
Skłodowski K, Suprewicz Ł, Chmielewska-Deptuła SJ, Kaliniak S, Okła S, Zakrzewska M, Minarowski Ł, Mróz R, Daniluk T, Savage PB, Fiedoruk K, Bucki R. Skłodowski K, et al. Among authors: fiedoruk k. Front Microbiol. 2023 Nov 17;14:1290952. doi: 10.3389/fmicb.2023.1290952. eCollection 2023. Front Microbiol. 2023. PMID: 38045035 Free PMC article.
Ceragenins exhibit antiviral activity against SARS-CoV-2 by increasing the expression and release of type I interferons upon activation of the host's immune response.
Suprewicz Ł, Szczepański A, Lenart M, Piktel E, Fiedoruk K, Barreto-Duran E, Kula-Pacurar A, Savage PB, Milewska A, Bucki R, Pyrć K. Suprewicz Ł, et al. Among authors: fiedoruk k. Antiviral Res. 2023 Sep;217:105676. doi: 10.1016/j.antiviral.2023.105676. Epub 2023 Jul 20. Antiviral Res. 2023. PMID: 37481038
Physicochemical Nature of SARS-CoV-2 Spike Protein Binding to Human Vimentin.
Deptuła P, Fiedoruk K, Wasilewska M, Suprewicz Ł, Cieśluk M, Żeliszewska P, Oćwieja M, Adamczyk Z, Pogoda K, Bucki R. Deptuła P, et al. Among authors: fiedoruk k. ACS Appl Mater Interfaces. 2023 Jul 19;15(28):34172-34180. doi: 10.1021/acsami.3c03347. Epub 2023 Jul 6. ACS Appl Mater Interfaces. 2023. PMID: 37413693 Free PMC article.
Blood-brain barrier function in response to SARS-CoV-2 and its spike protein.
Suprewicz Ł, Fiedoruk K, Czarnowska A, Sadowski M, Strzelecka A, Galie PA, Janmey PA, Kułakowska A, Bucki R. Suprewicz Ł, et al. Among authors: fiedoruk k. Neurol Neurochir Pol. 2023;57(1):14-25. doi: 10.5603/PJNNS.a2023.0014. Epub 2023 Feb 22. Neurol Neurochir Pol. 2023. PMID: 36810757 Free article. Review.
Cathelicidin LL-37 in Health and Diseases of the Oral Cavity.
Tokajuk J, Deptuła P, Piktel E, Daniluk T, Chmielewska S, Wollny T, Wolak P, Fiedoruk K, Bucki R. Tokajuk J, et al. Among authors: fiedoruk k. Biomedicines. 2022 May 7;10(5):1086. doi: 10.3390/biomedicines10051086. Biomedicines. 2022. PMID: 35625823 Free PMC article. Review.
38 results